Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Translating B cell immunology to the treatment of antibody-mediated allograft rejection
Peter S. Heeger, Maria Carrera Haro, Stanley C. Jordan
Nature Reviews Nephrology (2024) Vol. 20, Iss. 4, pp. 218-232
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
Katharina A Mayer, Eva Schrezenmeier, Matthias Diebold, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 2, pp. 122-132
Closed Access | Times Cited: 49
Identification of indirect CD4+ T cell epitopes associated with transplant rejection provides a target for donor-specific tolerance induction
Zhuldyz Zhanzak, Aileen C. Johnson, P. S. Foster, et al.
Immunity (2025)
Closed Access | Times Cited: 2
CD38 monoclonal antibody felzartamab for late antibody-mediated rejection: a phase II drug evaluation
Katharina A. Mayer, Klemens Budde, Martina Schatzl, et al.
Expert Opinion on Investigational Drugs (2025)
Open Access
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders
Azhagu Madhavan Sivalingam
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients
Yoichi Kakuta, Yoko Maegawa‐Higa, Soichi Matsumura, et al.
Clinical Transplantation (2025) Vol. 39, Iss. 2
Open Access
The immune duality of osteopontin and its therapeutic implications for kidney transplantation
Junto Leung, Lei Qu, Qifa Ye, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Research Advances of the Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation in Children
城艳 蒋
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1559-1571
Closed Access
2025: status of cardiac xenotransplantation including preclinical models
Guerard W. Byrne, Christopher G.A. McGregor
Frontiers in Transplantation (2025) Vol. 4
Open Access
CD19+ B cell depletion: a novel strategy to alleviate ischemic stroke damage
Yu Xu, Jing Peng, Yizhong Yan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies
Matthias Diebold, P. Gauthier, Katharina A. Mayer, et al.
Nature Medicine (2025)
Open Access
Chronic Rejection After Kidney Transplantation
Matthias Diebold, Katharina A. Mayer, Luis Hidalgo, et al.
Transplantation (2024)
Open Access | Times Cited: 3
Shared Genes and Pathways in Ulcerative Colitis and Ankylosing Spondylitis: Functional Validation and Implications for Diagnosis
Lin Li, Guangqi An, Fuzhen Li, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1657-1678
Open Access
Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept
Evaldo Favi, Donata Cresseri, Marta Perego, et al.
Clinical Immunology (2024) Vol. 264, pp. 110240-110240
Open Access | Times Cited: 3
Identification of hypoxia-immune-related signatures for predicting immune efficacy in triple-negative breast cancer
Luping Wang, Haote Han, Jiahui Ma, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 433-444
Open Access | Times Cited: 2
New therapies for highly sensitized patients on the waiting list
Ashley Vo, Noriko Ammerman, Stanley C. Jordan
Kidney360 (2024) Vol. 5, Iss. 8, pp. 1207-1225
Open Access | Times Cited: 2
Targeting CD38 in Subclinical Antibody-mediated Rejection in HLA-incompatible Kidney Transplantation: A Case Report
Ondřej Viklický, Petra Hrubá, Marek Novotny, et al.
Transplantation Direct (2024) Vol. 10, Iss. 8, pp. e1685-e1685
Open Access | Times Cited: 2
Anti‐pig antibodies in swine veterinarian serum: Implications for clinical xenotransplantation
Guerard W. Byrne, Christopher G.A. McGregor
Xenotransplantation (2024) Vol. 31, Iss. 3
Open Access | Times Cited: 1
Identification of molecular subtypes, prognostic status and immunotherapy response in cervical cancer based on angiogenic signature genes
Zhuo Deng, Lu Zhang, Chenyang Sun, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38488-e38488
Open Access | Times Cited: 1
New Immunosuppressants in Pediatric Kidney Transplantation: What's in the Pipeline for Kids?
Burkhard Toenshoff, Christian Patry, Alexander Fichtner, et al.
Pediatric Transplantation (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Unlocking Transplant Tolerance with Biomaterials
John‐Paul A. Pham, María M. Coronel
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 1
Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know
Yang Zhou, Yu‐Lun Chen, Xi-Yi Huang, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 3, pp. 375-394
Open Access
Interchain Disulfide Engineering Enables Efficient Production of Functional HLA-DQ-Fc Fusion Proteins
Xiamuxiya Aisihaer, Hongjie Guo, Chang Liu
Journal of Biological Chemistry (2024) Vol. 300, Iss. 9, pp. 107652-107652
Open Access
Effect of felzartamab anti-CD38 treatment on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies.
Philip F. Halloran, Matthias Diebold, P. Gauthier, et al.
Research Square (Research Square) (2024)
Open Access
Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal Allografts
Stanley C. Jordan
Transplantation (2024)
Closed Access
Investigating the Role of B Cell Receptors in Pathogen Recognition and Immune Response Activation: Implications for Infection Control and Therapeutic Development
Selin Özalp
Next frontier. (2024) Vol. 8, Iss. 1, pp. 169-169
Closed Access
Page 1 - Next Page

Scroll to top